Assessment of treatment with orotate magnesium in early postoperative period of patients with cardiac insufficiency and coronary artery by-pass grafts (ATOMIC).

What Was Tested

The paper reports a study of Orotic Acid, published as a randomized controlled trial.

Respecting the inclusion criteria were selected 32 patients with ischemia chronic failure in early postoperative period after CABG.

Who Took Part

According to the abstract, 32 patients were involved.

PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.

How the Study Was Run

The design is described as randomized, single-blind and placebo-controlled.

Random assignment meant chance, not the researchers, decided who got Orotic Acid and who got the comparison, which limits bias.

In this single-blind Orotic Acid study one party knew the assignments and the other did not.

A placebo (an inactive look-alike) gave the Orotic Acid group a baseline to be compared against.

What Was Measured

The subject headings attached to it are Coronary Artery Bypass, Echocardiography, Exercise Test, Myocardial Ischemia, Orotic Acid, Postoperative Complications and Quality of Life.

What This Means in Plain Language

The paper is a randomized, single-blind and placebo-controlled study of Orotic Acid in 32 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2004 (Romanian journal of internal medicine = Revue roumaine de medecine interne), a journal based in Germany.

More context: all human trials.